The legacy of Viagra, and its developer copyright, presents a intriguing case study for investors. Originally a blockbuster drug, generating billions in income, its intellectual property lapse created a flood https://doctorbookmark.com/story21464823/sildenafil-and-pharma-a-risky-opportunity